Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-06

Clinical Trial Update: A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing safety and immunogenicity of rabies pre-exposure prophylaxis regimens approved by Government of India versus WHO; current status unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabies pre-exposure prophylaxis regimen (Gvt of India approved)
  • Rabies pre-exposure prophylaxis regimen (WHO approved)

Snippet

Sponsor: Kempegowda Institute of Medical Sciences, Bangalore | Conditions: Vaccine Reaction | Phase 3 | Status: UNKNOWN